Furegrelate sdium

CAS: 85666-17-7

Ref. 3D-KDA66617

Produktinformation

• Name: Furegrelate sdium
• Synonyme: Furegrelate, 5-(3'-Pyridinylmethyl)benzofuran-2-carboxylate sodium, Sodium 5-(3-pyridinylmethyl)-2-benzofurancarboxylate, U 63557A, 2-Benzofurancarboxylic acid, 5-(3-pyridinylmethyl)-, sodium salt, Sodium 5-(Pyridin-3-Ylmethyl)-1-Benzofuran-2-Carboxylate

Beschreibung

Furegrelate is a prodrug that undergoes enzymatic biotransformation to its active form, furogrelate. Furogrelate is an inhibitor of angiogenesis, which is the growth of new blood vessels from pre-existing ones. Furogrelate inhibits the 2 enzymes required for the synthesis of fumarate and succinate, which are key intermediates in the biosynthesis of fatty acids. This inhibition leads to a decrease in fatty acid production and in turn, decreases formation of new blood vessels. Furogrelate also has anti-inflammatory properties and has been shown to inhibit tumor growth in experimental cancer models.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 275.24 g/mol
• Formel: C₁₅H₁₀NO₃·Na
• Reinheit: Min. 95%